Skip Navigation

Cardiovascular Research 2004 61(1):132-142; doi:10.1016/j.cardiores.2003.10.003
© 2004 by European Society of Cardiology
This Article
Right arrow Full Text Freely available
Right arrow FREE Full Text (PDF) Freely available
Right arrow E-letters: Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when E-letters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrowRequest Permissions
Right arrow Disclaimer
Google Scholar
Right arrow Articles by Kondoh, K.
Right arrow Articles by Shigematsu, H.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Kondoh, K.
Right arrow Articles by Shigematsu, H.
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

Copyright © 2004, European Society of Cardiology

Conduction performance of collateral vessels induced by vascular endothelial growth factor or basic fibroblast growth factor

Keisuke Kondoha,b,c, Hiroyuki Koyamaa,b,c,*, Tetsuro Miyatac, Tsuyoshi Takatob, Hirohumi Hamadad and Hiroshi Shigematsuc

aDepartment of Vascular Regeneration, Graduate School of Medicine, The University of Tokyo, Tokyo, Japan
bDivision of Tissue Engineering, The University of Tokyo Hospital, Tokyo, Japan
cDivision of Vascular Surgery, Department of Surgery, Graduate School of Medicine, The University of Tokyo, 7-3-1, Hongo, Bunkyo, Tokyo 113-8655, Japan
dDepartment of Molecular Medicine, Sapporo Medical University, Sapporo, Japan

* Corresponding author. Division of Vascular Surgery, Department of Surgery, Graduate School of Medicine, The University of Tokyo, 7-3-1, Hongo, Bunkyo, Tokyo 113-8655, Japan. Tel.: +81-3-5800-8653; fax: +81-3-3811-6822. hkoyama-tky{at}umin.ac.jp

Objective: In the present study, we delivered vascular endothelial growth factor (VEGF) and basic fibroblast growth factor (bFGF) gene to a rabbit model of hind limb ischemia utilizing an ex vivo method of gene transfer, and evaluated the functional performance of the developed collateral vessels. Method: The left femoral artery of a male Japanese White rabbit was excised to induce limb ischemia, and a section of skin was resected for culture of auto-fibroblasts. Twenty days later, the VEGF gene, bFGF gene or β-galactosidase gene (LacZ) was adenovirally transferred to the cultured auto-fibroblasts (5 x 106 cells), and the next day, a pair of specifically infected fibroblasts (total 1 x 107 cells) was injected via the left internal iliac artery of the same rabbit. Pairs of transferred genes into the fibroblasts were as follows: LacZ/LacZ (control group), VEGF/LacZ (VEGF group), bFGF/LacZ (FGF group) and VEGF/bFGF (combination group). Twenty-eight days after cell administration, collateral development and its function were evaluated. Results: Calf blood pressure ratio, resting blood flow of the left iliac artery and capillary density of ischemic muscle showed similar degrees of angiogenic effects in the VEGF and FGF groups, which were significantly greater than those in the control group. On the contrary, angiographic score, collateral conductance and smooth muscle cell (SMC)-positive vessel density in the FGF group were significantly greater than those in the VEGF group. In the combination group, collateral conductance showed synergistic effects, and in vivo blood flow and smooth muscle cell-positive vessel density revealed additive effects of VEGF and bFGF. Conclusion: These findings suggested that bFGF-induced collateral development exceeded VEGF-induced collateral development in the induction of arteriogenesis, and that combined gene delivery of VEGF and bFGF produced additive or synergistic effects of collateral development as compared with the effects induced by transfer of each gene alone.

KEYWORDS Vascular endothelial growth factor; Basic fibroblast growth factor; Therapeutic angiogenesis; Arteriogenesis; Ex vivo gene transfer; Collateral vessels


Time for primary review 24 days


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
Am. J. Roentgenol.Home page
A. Seko, N. Nitta, A. Sonoda, S. Ohta, M. Takahashi, K. Murata, and Y. Tabata
Vascular Regeneration by Repeated Infusions of Basic Fibroblast Growth Factor in a Rabbit Model of Hind-Limb Ischemia
Am. J. Roentgenol., June 1, 2009; 192(6): W306 - W310.
[Abstract] [Full Text] [PDF]


Home page
Circ. Res.Home page
A. Limbourg, M. Ploom, D. Elligsen, I. Sorensen, T. Ziegelhoeffer, A. Gossler, H. Drexler, and F. P. Limbourg
Notch Ligand Delta-Like 1 Is Essential for Postnatal Arteriogenesis
Circ. Res., February 16, 2007; 100(3): 363 - 371.
[Abstract] [Full Text] [PDF]


Home page
Circ. Res.Home page
C.-H. Chen and J. P. Walterscheid
Plaque Angiogenesis Versus Compensatory Arteriogenesis in Atherosclerosis
Circ. Res., October 13, 2006; 99(8): 787 - 789.
[Full Text] [PDF]


Home page
CirculationHome page
G. S. Werner, E. Jandt, A. Krack, G. Schwarz, O. Mutschke, F. Kuethe, M. Ferrari, and H. R. Figulla
Growth Factors in the Collateral Circulation of Chronic Total Coronary Occlusions: Relation to Duration of Occlusion and Collateral Function
Circulation, October 5, 2004; 110(14): 1940 - 1945.
[Abstract] [Full Text] [PDF]



Disclaimer: Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.